Time to Reconsider CARBON SCIENCES INCORPORATED (OTCMKTS:CABN) After More Short Sellers?

September 17, 2017 - By Maria Brooks

The stock of CARBON SCIENCES INCORPORATED (OTCMKTS:CABN) registered an increase of 73.91% in short interest. CABN’s total short interest was 12,000 shares in September as published by FINRA. Its up 73.91% from 6,900 shares, reported previously. With 104,500 shares average volume, it will take short sellers 0 days to cover their CABN’s short positions.

The stock decreased 9.32% or $0.0055 on September 15, reaching $0.0535. About 66,532 shares traded or 36.27% up from the average. Carbon Sciences, Inc. (OTCMKTS:CABN) has 0.00% since September 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Carbon Sciences, Inc. is a development-stage company. The company has market cap of $1.96 million. The Firm is engaged in researching and developing graphene technologies and devices. It has a 5 P/E ratio. It focuses on licensing its graphene manufacturing processes and device creates to other companies.

More notable recent Carbon Sciences, Inc. (OTCMKTS:CABN) news were published by: Marketwired.com which released: “Carbon Sciences Names New CEO” on March 08, 2016, also Globenewswire.com with their article: “Carbon Sciences to Become Digital Locations, Inc.” published on September 08, 2017, Prnewswire.com published: “Carbon Sciences Extends Graphene Research Project with University of …” on June 07, 2016. More interesting news about Carbon Sciences, Inc. (OTCMKTS:CABN) were released by: Marketwired.com and their article: “Carbon Sciences Appoints Silicon Valley Veteran as Technical Advisor” published on April 07, 2015 as well as Seekingalpha.com‘s news article titled: “New CEO for Carbon Sciences” with publication date: July 06, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: